Trial Profile

Phase 2/3 study of Breast-cancer-vaccine

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 03 Dec 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Nov 2025 According to Anixa Biosciences media release, Anixa plans to advance the vaccine into a Phase 2 clinical trial and will assume full sponsorship of the IND. For this it has executed a data transfer agreement (DTA) with Cleveland Clinic, as a key step in the process of transferring the breast cancer vaccine clinical trial data and sponsorship to Anixa for future clinical development.
30 Apr 2024 According to Anixa Biosciences media release, this Phase 2 trial is expected to commence in early 2025
12 Dec 2023 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com